ALLOGENIC TRANSPLANTATION OF HEMOPOIETIC STEM CELLS IN THE TREATMENT FOR CHRONIC MYELOLEUKEMIA
https://doi.org/10.51523/2708-6011.2011-8-2s-5
Abstract
The article presents the data on the treatment for chronic myeloleukemia with the application of allogenic transplantation of hemopoietic stem cells. The analysis of the received results testifies to the fact that the allogenic transplantation of hemopoietic stem cells is a highly effective method of the treatment of patients with chronic myeloleukemia.
References
1. Maziarz, R T. Who to transplant with CML in the era of tyrosine kinase inhibitors? / R T. Maziarz // Curr. Opin. Hematol. - 2008. - Vol. 15(2). - P. 127-133.
2. Goldman, J. M. Long term outcome aftr allogeneic stem-cell transplantation for CML / J. M. Goldman // Hematol J. - 2004. - Vol. 5. - P. 98.
3. Goldman, J. M. How I treat chronic myeloid leukemia in the imatinib era / J. M. Goldman // Blood. - 2007. - 110(8). - P. 2828-2837.
4. Allogeneic hematopoietic stem-cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results - an analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) / A. Gratwohl [et al.] // Haematologica. - 2006. - Vol. 91. - P. 513-521.
Review
For citations:
Dzyuba E.V. ALLOGENIC TRANSPLANTATION OF HEMOPOIETIC STEM CELLS IN THE TREATMENT FOR CHRONIC MYELOLEUKEMIA. Health and Ecology Issues. 2011;(2S):24-26. (In Russ.) https://doi.org/10.51523/2708-6011.2011-8-2s-5
Views: 241
Email this article 